Hyperfine, Inc.
Moat Score — Hyperfine, Inc.
Total Moat Score
13 / 30
| Moat Factor | Score | Analysis |
|---|---|---|
| Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. | 4 / 5 | Hyperfine holds 197 issued patents and 160 pending applications (as of February 2026) covering its ultra-low-field hardware and Optive AI reconstruction software, and it was the first company to win FDA clearance for a portable, ULF MR brain imaging system. The software is the actual reason a 0.064T scanner produces clinically usable images, making the IP genuinely load-bearing rather than defensive. |
| Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. | 1 / 5 | Hyperfine has no cost-scale advantage; it is a sub-$15M-revenue company manufacturing through a single contract partner (Benchmark Electronics) with single-sourced magnets, FPGAs, and CPUs, which if anything creates a cost and supply-chain vulnerability rather than an edge versus GE, Siemens, or Philips. |
| Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. | 2 / 5 | As an early-commercialization device competing for capital-constrained hospital and neurology-practice budgets against a claimed $16B addressable market, Hyperfine has limited ability to set premium pricing; its main lever is positioning Swoop as a lower-cost complement to, not a replacement for, high-field MRI. |
| Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. | 1 / 5 | There is a mild data flywheel in that a larger installed base could in theory improve Optive AI's training data, but Hyperfine has not disclosed this as a formal mechanism and the installed base (low thousands of sites at most) is far too small today to constitute a meaningful network effect. |
| Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. | 3 / 5 | Once a hospital or practice adopts Swoop under a 36- to 60-month software, service, and support agreement and integrates it into PACS workflows and clinical protocols, replacing it mid-contract is disruptive and costly, giving Hyperfine real but not extreme retention within its existing installed base. |
| Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. | 2 / 5 | Portable ULF brain MRI is a nascent category with only a handful of credible rivals (Neuro42, DeepSpin, Multiwave) and high regulatory barriers to entry via FDA clearance, but the category itself remains small and unproven, so the 'efficient scale' protection is more a function of category immaturity than a durable structural barrier. |